Association of Bariatric Surgery Status with Reduced HER2+ Breast Cancers: a Retrospective Cohort Study
Autor: | David A. Harris, Mehra Golshan, Elisha Pranckevicius, Keyvan Heshmati, Eric G. Sheu, Jennifer A. Ligibel, Bernard Rosner, Ali Tavakkoli, Nancy L. Cho, Ali Ardestani, Winnie T Ng |
---|---|
Rok vydání: | 2019 |
Předmět: |
Oncology
medicine.medical_specialty Nutrition and Dietetics Multivariate analysis business.industry Endocrinology Diabetes and Metabolism Medical record Cancer 030209 endocrinology & metabolism Retrospective cohort study medicine.disease 03 medical and health sciences 0302 clinical medicine Breast cancer Internal medicine medicine 030211 gastroenterology & hepatology Surgery Stage (cooking) business Generalized estimating equation Body mass index |
Zdroj: | Obesity Surgery. 29:1092-1098 |
ISSN: | 1708-0428 0960-8923 |
Popis: | Bariatric surgery is associated with a reduced risk of developing certain malignancies, particularly in women. However, the impact of bariatric surgery on tumor characteristics, cancer treatment, and oncologic outcomes is unknown. In a retrospective cohort study, 42 subjects diagnosed with breast cancer after bariatric surgery (1989–2014) were matched to 84 subjects with breast cancer (1984–2012) who did not undergo bariatric surgery, based on age, body mass index (BMI), and menopausal status at the time of breast cancer diagnosis, as well as the date of cancer diagnosis. Medical records were reviewed for cancer and bariatric endpoints. Statistical analysis was performed using mixed effects regression models, generalized estimating equation, conditional logistic regression, and Fisher’s exact tests. Women who developed breast cancer after bariatric surgery presented at an earlier stage compared to non-operated, obese controls. In the bariatric surgery group, there were fewer tumors with human epidermal growth factor receptor 2 overexpression (HER2+) (OR 0.16 (0.03–0.76); p = 0.02), with no significant differences seen in estrogen and progesterone receptor positivity. No HER2+ cancers were found in patients who underwent Roux-en-Y gastric bypass (OR 0.00 (0.00–0.43); p = 0.002). On multivariate analysis, bariatric surgery status remained associated with reduced HER2+ breast cancers (OR 0.18 (0.03–0.99); p |
Databáze: | OpenAIRE |
Externí odkaz: |